Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3905641000168110 | Betahistine (GxP) (betahistine dihydrochloride 16 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3905651000168112 | Betahistine (GxP) 16 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betahistine (GxP) 16 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Betahistine (GxP) 16 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Betahistine (GxP) 16 mg tablet | Is a | betahistine dihydrochloride 16 mg tablet | true | Inferred relationship | Some | ||
| Betahistine (GxP) 16 mg tablet | Is a | Betahistine (GxP) | true | Inferred relationship | Some | ||
| Betahistine (GxP) 16 mg tablet | has manufactured dose form | uncoated tablet | false | Inferred relationship | Some | ||
| Betahistine (GxP) 16 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1074447536 | |
| Betahistine (GxP) 16 mg tablet | has intended active ingredient | betahistine | true | Inferred relationship | Some | 1074447535 | |
| Betahistine (GxP) 16 mg tablet | has Australian BoSS | betahistine dihydrochloride | true | Inferred relationship | Some | 1074447535 |
Reference Sets
Trade product unit of use reference set
FHIR